Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicenter IDEAL-LM trial

Miguel Lemmert, K Oldroyd, P Barragan, M Lesiak, RA Byrne, E Merkulov, Joost Daemen, Yoshinobu Onuma, Karen Witberg, Robert Jan van Geuns

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
3 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)104-111
Number of pages8
JournalAmerican Heart Journal
Volume187
DOIs
Publication statusPublished - 2017

Cite this